Cost-effectiveness of adjuvant imatinib in intermediate-risk gastrointestinal stromal tumors (GIST)

ANNALS OF SURGICAL ONCOLOGY(2024)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要